Tag Archives: HBV

Where is the quality of life data elicited from? Patients, experts or the general public and from what setting. Does the source or type of quality of life data impact the strength of findings or introduce a bias?Discuss

Description Critically analyse a published economic evaluation by Williams et al (VALUE IN HEALTH. 2020; 23(8):1003–1011) on the cost-effectiveness of opt-out emergency department-based Hepatitis B (HBV) and Hepatitis C (HCV) testing and linkage to care, compared to no emergency department testing in the UK. What are the key data sources used and are they appropriate? […]